Sensydia Corporation
Publicly observedLos Angeles, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Los Angeles | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Sensydia Corporation | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | ZE43PM9FX1H9 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant5 May 2023Publicly observed
NIH SBIR/STTR award: A non-invasive, automated platform for hemodynamic assessment of patients at risk of heart failure or pulmonary hypertension
USD 816,106.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant5 May 2023Publicly observed
NIH SBIR/STTR award: A non-invasive, automated platform for hemodynamic assessment of patients at risk of heart failure or pulmonary hypertension
USD 1,607,970.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.